Defective Drugs

On March 21, 2022, Pfizer announced a voluntary recall of three of the company’s blood pressure medications. The recall applies to the company’s brand-name blood pressure medication Accuretic (quinapril HCl/hydrochlorothiazide) as well as two generic medications, quinapril with hydrochlorothiazide and quinapril HCl/hydrochlorothiazide. These two generic medications are distributed by a […]

Antibiotics are among the most common—and most important—medications used in modern society. They are used to prevent and treat an extremely broad range of infections, many of which present life-threatening risks. Unfortunately, like other types of medicines, antibiotics also present some risks of their own. For example, the U.S. Food […]

Rosiglitazone (marketed under the trade name Avandia) is an antidiabetic drug that is used for the treatment of patients with type 2 diabetes. It is one of several antidiabetic drugs sold in the United States—along with Avandamet, Avandaryl, and metformin with sulfonylurea. While the U.S. Food and Drug Administration (FDA) […]

Over the past couple of years, patients with retinal damage have been filing lawsuits against the makers of Elmiron (pentosan polysulfate sodium), the only drug approved to treat interstitial cystitis. The judge overseeing the Elmiron multidistrict litigation (MDL), which is housed in the United States District Court for the District […]

In early October of this year, the brand name makers of Zantac lost a major court ruling in the federal multidistrict litigation (MDL). The judge overseeing the matter, Judge Robin L. Rosenberg of the Southern District of Florida, issued an order that allows plaintiffs to seek “medical monitoring” claims concerning […]

Popular blood pressure drugs have faced multiple recalls over the past few years relating to a carcinogen, N-Nitrosodimethylamine (NDMA), found in the drugs. Valsartan and losartan are two big examples, with millions of patients taking these blood pressure drugs worldwide. Just as manufacturers are dealing with the aftermath of massive […]